First of all, it is up to the experts to decide who gets the Covid-19 vaccine


U.S. A limited supply of coronavirus vaccine doses will be available immediately after vaccination by the Food and Drug Administration.

“Apart from health care workers, the people who will be the first to get it will be people who have severe underlying medical conditions in old age, as well as communities of color who have been disproportionately affected by this epidemic.” .

“Now it’s starting to get a little more controversial in those groups,” he added. “As opposed to the 65-year-old African American, how would you prioritize between an 85-year-old woman in a nursing home – especially when the risk of a significant disease could be as high as that of a 65-year-old?”

Committees for the Advisory on Disease Control and Prevention will recommend the ACIP group for the immune system to be vaccinated first.

“That’s where it gets a little more political and honest, this is where the president-elect is leaving public health experts and scientists to decide how best to allocate a limited supply there.”

The ACIP called an emergency meeting for December 1, where they would vote on the first group to be vaccinated.

“Because we know that the vaccine will be available in very limited quantities, even if they give preference to health care workers and the elderly in their population, it will be really important to be a little more grainy,” said Rick Bright, another member. Biden’s Coronavirus Advisory Council.

“They’re going to discuss that granularity among health care workers. If I only have multiple doses available, how can I prioritize those health care workers first and give those recommendations to the states?” He added.

CDC ready for Biden transition: 'This is what we are waiting for'.

Specifically, ACIPs are obtained after being vaccinated by the FDA for FID recommendation, but they are actively working in anticipation of a quick decision by the FDA.

“We look forward to proximity authorization if this vaccine is shown to be effective and safe in the near future and we want to be in a position where we are giving proper guidance to states and jurisdictions for the use of these vaccines,” said ACIP President Dr. Jose Romero told CNN.

Romero, health secretary of the Arkansas Department of Health, said Tuesday’s vote was about the first group to receive vaccinations, which could include healthcare providers and long-term people, aggregated facilities.

Pfizer has applied to the FDA for authorization of emergency use for its vaccine. An independent panel of experts from the FDA’s Vaccine and Related Biological Products Advisory Committee is scheduled to meet on December 10 to discuss the application. FDA officials say a decision should be made within a few weeks of the meeting and as soon as possible.

.